RKRabia Kanwar

Rabia Kanwar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rabia Kanwar has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Phage Antibiotic Synergism: A Promising Approach for Tackling Emerging Challenge of Antibiotic Resistance

    by Kinza Idress, Rabia Kanwar, Sehrish Nayab, Sohaib H. Mazhar‬, Muhammad Aamir Aslam

    Rekindling attention has been directed towards phage therapy, a technique that utilizes phages to eradicate bacterial infections by targeting specific bacteria. This review delves into the interplay between bacteriophages and antibiotics, with a focus on the emerging concept of phage-antibiotic synergism (PAS). The escalating threat of antibiotic resistance and its advancing mechanisms for resistance development underscore the imperative need for alternative approaches to treat life-threatening infections. Consideration of bacteriophages that can specifically target and eliminate particular bacteria is gaining prominence for the improved treatment of infections. Moreover, the combination of both phages and antibiotics is viewed as a more efficient means of achieving treatment objectives. The observed synergistic effects in phage-antibiotic therapies showcase proficiency in antimicrobial activity, leading to a reduction in the development of microbial resistance towards antibiotics by providing an alternative way for bacterial eradication. Key findings from recent reviews emphasize the diverse mechanisms underlying phage-antibiotic synergism, including bacterial morphological changes, interference with biofilm formation, efflux pumps, increased cell wall permeability, and the potential to overcome antibiotic-resistant strains. Furthermore, this review paper elaborates on the significance of understanding the interaction between phages and antibiotics to enhance therapeutic outcomes along with an effort to shed light on the merits and demerits of this combined therapy. This comprehensive understanding can pave the way for an innovative approach to infectious disease treatment and management.

  • Open Access

    Next Generation of Modern Approaches for Phage Therapy for Treating Multidrug-Resistant Bacterial Pathogens

    by Sehrish Nayab, Rabia Kanwar, Muhammad Aamir Aslam

    Bacteriophages are viruses that attack bacterial cells, resulting in their lysis. Since the emergence of antibiotic resistance, phages have gained attention from the scientific community and are being explored for their potential use as anti-microbial agents. Since their discovery, naturally occurring wild-type phages have been used as anti-microbial agents. Though usage of antibiotics is confronted with problems, antibiotic resistance being the most pronounced, phages also have limitations, such as harboring toxin genes, not always lytic in nature, being involved in transduction, not having a broad host range, having a short life in the body due to mammalian immune response, and being attacked by bacterial anti-phage defense mechanisms. Modern approaches to phage therapy can address these problems associated with conventional phage therapy. These modern approaches include genetic phage engineering and using phage-derived enzymes, such as depolymerases and endolysins, in their wild-type form as well as in genetically engineered form. Genetic engineering has been performed on lytic, lysogenic, and filamentous phages for desired targeted results. In this review, we discuss the previous studies that have investigated these modern approaches for phage therapy against bacterial infections. Advantages and disadvantages of phage therapy are being discussed, and it is discussed how the use of modern approaches can affect different aspects of phage therapy.

  • Open Access

    Integrative role of yeast culture metabolites in aquatic health and productivity

    by Sajjad Ur Rahman, Dur E Nayab, Rabia Kanwar, Muhammad Mukarram Bashir

    Aquaculture is an important source for the animal protein obtained through extensive farming. Worldwide aquaculture sector consistently confronts the challenges such as non-specific infections, low productivity and environmental stress. Saccharomyces cerevisiae being commonly utilized yeast species in aquaculture nutrition, especially for its growth-enhancing and health-promoting attributes in various cultured fish and crustacean species. Yeast culture metabolites (YCM) have emerged up as valuable feed ingredient to promote essential microbiota in ponds. Research on aquatic species such as tilapia, salmons and shrimps has shown that yeast metabolites beneficially affect growth performance, feed conversion ratio, digestive physiology, and gut morphology. The functional components regulate and activate immune responses, ultimately enhancing resistance to infections and overall aquatic health. Feed utilization efficiency in aquaculture species with an average of between 8 and 18 % reduction in FCR, which is attributed to the use of these yeast metabolites as feed additives in terms of fish production sustainability. Despite the increasing volume of experimental research, the current understanding of application in aquaculture remains limited. This review summarizes what is currently known about yeast functional metabolites, formulations, and various aquaculture applications. The integration of metabolites in feeds promoting sustainable farming methods and resilience in contemporary aquaculture.

  • Synergistic effects of zP-1 phage and ampicillin against methicillin-resistant Staphylococcus aureus isolated from hospital staff

    by Zain Mehmood, Rabia Kanwar, Kaleem Ullah, Saqib Ali, Muhammad Aamir Aslam, Abdul Qadeer, Haiwad Gul, Mohamed Hassanein Mahmoud

    Background Methicillin-resistant Staphylococcus aureus (MRSA) strains are a major cause of hospital-acquired infections, exacerbated by increasing antibiotic resistance. Aim This study aimed to isolate bacteriophages targeting MRSA and evaluate their antimicrobial activity in combination with antibiotics. Methods Nasal samples from hospital staff (n = 50) were used to isolate MRSA strains, and sewage samples were processed for phage isolation using the double agar overlay technique. The microtitration plate method evaluated the synergistic effects of isolated phages and antibiotics. Results Out of 50 samples, 11 MRSA strains were positive, showing high resistance to multiple antibiotics, including oxacillin (95%), and vancomycin (85%). Phage zP-1, belonging to the Myoviridae family, exhibited > 90% lytic activity, stable across temperatures (20–50 °C) and pH (6–8). A statistically significant synergistic effect was observed at a MIC of 0.137 μg/ml for gentamicin (p-value 0.02). Conclusion These findings suggest that phage-antibiotic synergy may offer a promising strategy to combat MRSA infections, warranting further in vivo studies to assess its clinical potential.


  • Bacteriophages and Their Endolysin: An Alternative Therapeutic Approach for Bovine Mastitis

    by R. Kanwar, M. A. Aslam, H. Zulqurnain, A. Qadeer, S. Ali, S. Nayab, S. Mustafa

    Mastitis is one of the most prevalent and serious disease in bovines and led to high economic loss in the dairy industry. Mastitis dramatically reduces the reproduction abilities of cows. Despite significant progress in controlling and treating this disease, it is still frequent. Mastitis risks public health if milk from treated animals is taken by humans. Multiple factors are responsible for this disease, but bacterial mastitis is the most prevalent and threatening. The emergence of drug-resistant bacterial strains makes mastitis untreatable. Misuse of antibiotics in animal therapy is responsible for this issue, which resulted in the creation of strains that are multidrug resistant. This antibiotic resistance among bacteria is alarming. There is a need for an alternative treatment to cure mastitis. Bacteriophages are viruses, which kill bacteria. The effectiveness of bacteriophages and their endolysin against different bacterial infections causing mastitis has been approved from the results of various studies. Phage therapy is used as both a treatment and preventive measure.


  • Bacteriophages and their Endolysin: An Alternative Therapeutic Approach for Bovine Mastitis

    by R. Kanwar, M. A. Aslam, H. Zulqurnain, A. Qadeer, S. Ali, S. Nayab, S. Mustafa, Канвар Р., Зулькурнайн Х., Наяб С.

    Mastitis is one of the most prevalent and serious disease in bovines and led to high economic loss in the dairy industry. Mastitis dramatically reduces the reproduction abilities of cows. Despite significant progress in controlling and treating this disease, it is still frequent. Mastitis risks public health if milk from treated animals is taken by humans. Multiple factors are responsible for this disease, but bacterial mastitis is the most prevalent and threatening. The emergence of drug-resistant bacterial strains makes mastitis untreatable. Misuse of antibiotics in animal therapy is responsible for this issue, which resulted in the creation of strains that are multidrug resistant. This antibiotic resistance among bacteria is alarming. There is a need for an alternative treatment to cure mastitis. Bacteriophages are viruses, which kill bacteria. The effectiveness of bacteriophages and their endolysin against different bacterial infections causing mastitis has been approved from the results of various studies. Phage therapy is used as both a treatment and preventive measure.